Abstract:BACKGROUND: The prevalence of female infertility between the ages of 25 and 44 is 3.5% to 16.7% in developed countries and 6.9% to 9.3% in developing countries. This means that infertility affects one in six couples and is recognized by the World Health Organization as the fifth most serious global disability. The International Committee for Monitoring Assisted Reproductive Technology reported that the global total of babies born as a result of assisted reproductive technology procedures and other advanced fertility treatments is more than 8 million. Advancements in controlled ovarian hyperstimulation procedures led to crucial accomplishments in human fertility treatments. The European Society for Human Reproduction and Embryology guideline on ovarian stimulation gave us valuable evidence-based recommendations to optimize ovarian stimulation in assisted reproductive technology. Conventional ovarian stimulation protocols for in vitro fertilization (IVF)-embryo transfer are based upon the administration of gonadotropins combined with gonadotropin-releasing hormone (GnRH) analogues, either GnRH agonists (GnRHa) or antagonists. The development of ovarian cysts requires the combination of GnRHa and gonadotropins for controlled ovarian hyperstimulation. However, in rare cases patients may develop an ovarian hyper response after administration of GnRHa alone.CASE SUMMARY: Here, two case studies were conducted. In the first case, a 33-year-old female diagnosed with polycystic ovary syndrome presented for her first IVF cycle at our reproductive center. Fourteen days after triptorelin acetate was administrated (day 18 of her menstrual cycle), bilateral ovaries presented polycystic manifestations. The patient was given 5000 IU of human chorionic gonadotropin. Twenty-two oocytes were obtained, and eight embryos formed. Two blastospheres were transferred in the frozen-thawed embryo transfer cycle, and the patient was impregnated. In the second case, a 37-year-old woman presented to the reproductive center for her first donor IVF cycle. Fourteen days after GnRHa administration, the transvaginal ultrasound revealed six follicles measuring 17-26 mm in the bilateral ovaries. The patient was given 10000 IU of human chorionic gonadotropin. Three oocytes were obtained, and three embryos formed. Two high-grade embryos were transferred in the frozen-thawed embryo transfer cycle, and the patient was impregnated.CONCLUSION: These two special cases provide valuable knowledge through our experience. We hypothesize that oocyte retrieval can be an alternative to cycle cancellation in these conditions. Considering the high progesterone level in most cases of this situation, we advocate freezing embryos after oocyte retrieval rather than fresh embryo transfer.

Spontaneous Conception after IVF Treatment in Thirteen Patients with Tubal Factor Infertility

Factors Affecting the Live-Birth Rate in Women with Diminished Ovarian Reserve Undergoing IVF-ET

Evaluating Embryo Quality and Clinical Pregnancy in Cases of Tubal Factor Infertility

Factors Relating with Fertilization Failure in Conventional IVF-ET Cycles

Clinical Analysis of 34 Cases of Ectopic Pregnancy after in vitro Fertilization and Embryo Transfer

Exploration on Relative Factors of Ectopic Pregnancy after IVF-ET

Analysis of the Clinical Efficacy of Laparoscopy and Hysteroscopy in the Treatment of Tubal-Factor Infertility

Factors of Spontaneous Abortion in IVF-ET

Live births from in vitro fertilization-embryo transfer following the administration of gonadotropin-releasing hormone agonist without gonadotropins: Two case reports

The influencing factor analysis of in vitro fertilization and embryo transfer failure

Clinical Analysis of 12 491 Cycles Treated in Embryo Transfer Program

In vitro fertilization-embryo transfer in patients with unexplained recurrent pregnancy loss

Effects of age on pregnancy outcomes in patients with simple tubal factor infertility receiving frozen-thawed embryo transfer

[Analysis of 92 ectopic pregnancy patients after in vitro fertilization and embryo transfer].

M005 ANALYSIS OF CLINICAL FACTORS ON PREGNANCY LOSS DURING IVF‐ET TREATMENT

Fertilization Method for Primary Infertility Patients Without Definite Cause Undergoing in Vitro Fertilization and Embryo Transfer

Hysteroscopic Interventions in Patients Undergoing Repeatedly in vitro Fertilization-embryo Transfer Who Failed to Conceive

GV 20's Role in In Vitro Fertilization and Frozen Embryo Transfer

Vascular endothelial growth factor, ovarian Doppler blood flow and in vitro fertilization-embryo transfer

Pregnancy outcome after IVF in polycystic ovary syndrome, endometriosis, tubal factor-associated and ICSI in male factor infertility

Comparison of Clinical Outcomes Between Conventional in Vitro Fertilization and Intracytoplasmic Sperm Injection in Low Oocyte Retrieval Cycles